Observational study · people

Clomiphene: 6.8% of women with PCOS were resistant in PCOSAct

Checked against the paper Observational studyPublished by PepVault

The takeaway

For women with PCOS using clomiphene, higher testosterone and higher BMI before treatment were tied to a greater chance that clomiphene would not work.

Kind
Observational study
Studied in
People
Number studied
471
Published
2026
Journal
Front Endocrinol (Lausanne)

What they tested

The team wanted to find which measurements taken before treatment could predict which infertile women with PCOS would not respond to clomiphene.

How the study was done

A post hoc analysis, meaning a look back at data from a finished trial, of the 471 women in the clomiphene arm of the PCOSAct trial, a large randomized trial run at several centers in China. Only women who completed the follow-up were included, and the team used statistical models to link baseline measures to clomiphene resistance.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking clomiphene? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Of the 471 women, 32 (6.8%) were resistant to clomiphene. BMI, total testosterone and AMH (anti-Müllerian hormone) all helped predict how the ovaries responded. A model using only testosterone and BMI scored an AUC of 0.801, a measure of how well a model sorts people where higher is better, which was statistically similar to a model that also added AMH (AUC = 0.818; P = 0.347). Total testosterone was the strongest single predictor (OR = 2.73 per 1-unit), and BMI was the strongest risk factor that can be changed (OR = 2.49 per 1-SD).

What it doesn’t show

This was a post hoc look at one arm of a trial, so it shows links, not cause and effect, and it was based on only 32 women who were resistant. All the women were in China and had to have completed follow-up, so the results may not apply to everyone with PCOS.

The paper

Liu et al. Identification of predictors of the ovarian response to clomiphene citrate in infertile women with polycystic ovary syndrome: A post-hoc analysis of a randomized controlled trial. Front Endocrinol (Lausanne). 2026.

The compound

More studies on Clomiphene

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking clomiphene? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo